Prosecution Insights
Last updated: April 19, 2026

Sumagen Canada Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
2
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18280147 RECOMBINANT VSV-SARS-COV-2 VACCINE JUEDES, AMY E 1644 Final Rejection Sep 01, 2023
17918244 MERS-CoV VACCINE JUEDES, AMY E 1644 Final Rejection Oct 11, 2022

Managing Sumagen Canada Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month